Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers

NCT02130310 is registered in ClinicalTrials.gov with Macrocure Ltd. as lead sponsor.

NCT NCT02130310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Lead sponsor
Macrocure Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2014
Completion date
June 30, 2016
Enrollment
252 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous leg ulcers